Long-term effects of ischemic postconditioning on clinical outcomes: 1-year follow-up of the POST randomized trial

Joo-Yong Hahn1, Cheol Woong Yu2, Hun Sik Park3

  • 1Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Insights

Ischemic postconditioning did not improve 1-year clinical outcomes for ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. This study found no significant difference in major adverse events between postconditioning and conventional PCI groups.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Ischemic postconditioning has not demonstrably improved myocardial reperfusion in ST-segment elevation myocardial infarction (STEMI) patients.
  • Long-term clinical outcome data following ischemic postconditioning in STEMI patients are limited.

Purpose of the Study:

  • To evaluate the long-term (1-year) clinical outcomes of ischemic postconditioning in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (PCI).

Main Methods:

  • A randomized controlled trial involving 700 patients undergoing primary PCI, assigned 1:1 to postconditioning or conventional PCI.
  • Postconditioning involved brief balloon occlusions immediately after coronary flow restoration.
  • The primary outcome was a composite of death, myocardial infarction, severe heart failure, or stent thrombosis at 1 year, analyzed by intention-to-treat.

Main Results:

  • No significant difference in the composite outcome (6.1% vs 4.6%, P=.40) between the postconditioning and conventional PCI groups at 1 year.
  • Individual event rates for death, heart failure, and stent thrombosis also showed no significant differences between the groups.
  • Hazard ratios for the composite outcome and individual events were not statistically significant.

Conclusions:

  • Ischemic postconditioning does not appear to enhance 1-year clinical outcomes in STEMI patients undergoing primary PCI.
  • The findings suggest that ischemic postconditioning is not beneficial for reducing major adverse clinical events in this patient population.
Abstract